G. Jagetia
Journal of Clinical Immunology · 2007
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Whom G. Jagetia trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Jagetia overall
Papers from G. Jagetia's perspective
Ordered by how strongly the researchers G. Jagetia trusts endorse each paper. Same corpus, a different order for every researcher.
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* (Journal of Biological Chemistry)
- Toll-like receptors. (Critical Care Medicine)
- Medicinal plants in India. (The Indian journal of medical research)
- Anticancer potential of curcumin: preclinical and clinical studies. (Anticancer Research)
- Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. (Anticancer Research)
- Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. (Clinical Gastroenterology and Hepatology)
- Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis (Journal of Neuroscience)
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
- Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model (Journal of Neurochemistry)
- Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced… (Cancer Research)
Their papers
- “Spicing Up” of the Immune System by Curcumin (2007) — 609 citations